WHO publishes target product profiles for Taenia solium diagnostic tests
6 October 2026
The World Health Organization published target product profiles (TPPs) for Taenia solium diagnostics on 6 October 2026.
They cover diagnostic tests for taeniasis in humans and for cysticercosis in humans and pigs.
The profiles aim to stimulate investment and innovation in diagnostics that support neurocysticercosis (NCC) case management and strengthen T. solium control programmes.
They set out tests that detect T. solium-specific markers to identify areas with at least 0.5% taeniasis prevalence or 2% porcine cysticercosis prevalence.
They also describe point-of-care detection of viable cysts in the central nervous system and tests to identify symptomatic people needing referral where imaging is not available.
In plain words
TPP Target product profile — A document listing the features a new test or product should have.
Neurocysticercosis NCC — Infection of the central nervous system by T. solium cysts.